Alumis ALMS
NASDAQ ALMS
$6.35 -0.20 (-3.05%)
As of: Nov 10, 2026 · 3:35 PM EST

Alumis (ALMS) EBIT Margin (2025 - 2026)

Updated

Alumis' EBIT Margin came in at -8956.38% for Q2 2026, down 3684.85 percentage points from -5271.53% a year earlier.

Analysis

Alumis (ALMS) EBIT Margin (2025 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Alumis reported EBIT Margin of -6021.04%; for FY2025, it came in at -1886.92%.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 52.42%
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 24.35%
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 36.01%
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 30.89%
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 32.97%
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 20.57%
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 35.79%
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 41.71%
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 32.98%
10 Alumis 830.27 Mn -881.19 Mn - -8,956.38%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -8,956.38%
Dec 31, 2025 -4,999.74%
Sep 30, 2025 -5,580.45%
Jun 30, 2025 -5,271.53%
Mar 31, 2025 -583.49%
API Access

Alumis EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=ALMS&period=max&api_key=YOUR_API_KEY